The malaria drug Qualaquin (quinine sulfate) is available in both brand-name and generic form. The generic capsules come in one strength (324 mg) and are considered equivalent to the brand-name medication.
Qualaquin® (quinine sulfate) is a prescription medication licensed to treat uncomplicated (or mild) malaria. Brand-name Qualaquin is made by Mutual Pharmaceutical Company, Inc., for AR Scientific, Inc. It is also available in generic form.
Generic Qualaquin is available in one strength -- Quinine sulfate 324 mg capsules. It is made by various manufacturers, such as:
- Mutual Pharmaceutical Company, Inc., the same company that makes brand-name Qualaquin
- Teva Pharmaceuticals USA.
The version made by Mutual Pharmaceutical Company, Inc., is actually an “authorized generic,” meaning that it is the actual brand-name medication that is just packaged and sold under a generic name. It is exactly the same as Qualaquin in every way, except it comes in a bottle with a generic name.
All generic medications must undergo certain tests to compare them to brand-name medications. The U.S. Food and Drug Administration (FDA) then looks at these tests to decide if the generics are equivalent to the brand-name medications and assigns a rating to each one.
An "AB" rating means that the FDA has determined that a generic medication is equivalent to a brand-name medication. The generic Qualaquin versions currently available have an AB rating, meaning that they should be equivalent to Qualaquin.